Molecular screening strategies for NF1-like syndromes with café-au-lait macules (Review)

Mol Med Rep. 2016 Nov;14(5):4023-4029. doi: 10.3892/mmr.2016.5760. Epub 2016 Sep 22.

Abstract

Multiple café-au-lait macules (CALM) are usually associated with neurofibromatosis type 1 (NF1), one of the most common hereditary disorders. However, a group of genetic disorders presenting with CALM have mutations that are involved in human skin pigmentation regulation signaling pathways, including KIT ligand/KIT proto‑oncogene receptor tyrosine kinase and Ras/mitogen‑activated protein kinase. These disorders, which include Legius syndrome, Noonan syndrome with multiple lentigines or LEOPARD syndrome, and familial progressive hyperpigmentation) are difficult to distinguish from NF1 at early stages, using skin appearance alone. Furthermore, certain syndromes are clinically overlapping and molecular testing is a vital diagnostic method. The present review aims to provide an overview of these 'NF1‑like' inherited diseases and recommend a cost‑effective strategy for making a clear diagnosis among these diseases with an ambiguous borderline.

Publication types

  • Review

MeSH terms

  • Cafe-au-Lait Spots / diagnosis
  • Cafe-au-Lait Spots / genetics*
  • Cafe-au-Lait Spots / pathology
  • Diagnosis, Differential
  • Humans
  • LEOPARD Syndrome / diagnosis
  • LEOPARD Syndrome / genetics*
  • LEOPARD Syndrome / pathology
  • Mutation
  • Neurofibromatosis 1 / diagnosis
  • Neurofibromatosis 1 / genetics*
  • Neurofibromatosis 1 / pathology
  • Noonan Syndrome / diagnosis
  • Noonan Syndrome / genetics*
  • Noonan Syndrome / pathology
  • Pathology, Molecular
  • Signal Transduction / genetics
  • Skin Pigmentation / genetics

Supplementary concepts

  • Cafe au lait spots, multiple
  • Legius syndrome